Millennium Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Buy |
630,138
+398,963
| +173% | +$578K | ﹤0.01% | 3075 |
|
|
2025
Q1 | $319K | Buy |
+231,175
| New | +$319K | ﹤0.01% | 3465 |
|
|
2024
Q4 | – | Sell |
-48,672
| Closed | -$242K | – | 4477 |
|
|
2024
Q3 | $242K | Buy |
48,672
+20,783
| +75% | +$104K | ﹤0.01% | 3653 |
|
|
2024
Q2 | $163K | Sell |
27,889
-364,226
| -93% | -$2.13M | ﹤0.01% | 3627 |
|
|
2024
Q1 | $3.11M | Buy |
392,115
+293,033
| +296% | +$2.33M | ﹤0.01% | 2310 |
|
|
2023
Q4 | $578K | Buy |
+99,082
| New | +$578K | ﹤0.01% | 3106 |
|
|
2023
Q1 | – | Sell |
-19,244
| Closed | -$31K | – | 4959 |
|
|
2022
Q4 | $31K | Buy |
+19,244
| New | +$31K | ﹤0.01% | 4541 |
|
|
2022
Q1 | – | Sell |
-12,276
| Closed | -$55K | – | 5635 |
|
|
2021
Q4 | $55K | Sell |
12,276
-17,964
| -59% | -$80.5K | ﹤0.01% | 4980 |
|
|
2021
Q3 | $252K | Buy |
+30,240
| New | +$252K | ﹤0.01% | 4612 |
|